Spdr Sp Pharmaceuticals Etf Price To Earning
| XPH Etf | USD 44.05 0.49 1.10% |
SPDR SP Pharmaceuticals fundamentals help investors to digest information that contributes to SPDR SP's financial success or failures. It also enables traders to predict the movement of SPDR Etf. The fundamental analysis module provides a way to measure SPDR SP's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SPDR SP etf.
SPDR |
SPDR SP Pharmaceuticals ETF Price To Earning Analysis
SPDR SP's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current SPDR SP Price To Earning | 6.56 X |
Most of SPDR SP's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SPDR SP Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, SPDR SP Pharmaceuticals has a Price To Earning of 6.56 times. This is 3.53% lower than that of the SPDR State Street Global Advisors family and significantly higher than that of the Health category. The price to earning for all United States etfs is 108.25% lower than that of the firm.
SPDR Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SPDR SP's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of SPDR SP could also be used in its relative valuation, which is a method of valuing SPDR SP by comparing valuation metrics of similar companies.SPDR SP is currently under evaluation in price to earning as compared to similar ETFs.
Fund Asset Allocation for SPDR SP
The fund invests 99.9% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides SPDR SP's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
SPDR Fundamentals
| Price To Earning | 6.56 X | |||
| Price To Book | 1.51 X | |||
| Price To Sales | 2.83 X | |||
| Gross Profit | 2.66 M | |||
| Earnings Per Share | (11.87) X | |||
| Number Of Employees | 12 | |||
| Beta | 0.7 | |||
| Market Capitalization | 236.07 M | |||
| Total Asset | 206.63 M | |||
| One Year Return | 11.70 % | |||
| Three Year Return | 1.40 % | |||
| Five Year Return | 2.10 % | |||
| Ten Year Return | (0.30) % | |||
| Net Asset | 206.63 M | |||
| Last Dividend Paid | 0.067 | |||
| Equity Positions Weight | 99.90 % |
About SPDR SP Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SPDR SP Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SPDR SP using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SPDR SP Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether SPDR SP Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of SPDR SP's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Spdr Sp Pharmaceuticals Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Spdr Sp Pharmaceuticals Etf:Check out SPDR SP Piotroski F Score and SPDR SP Altman Z Score analysis. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
The market value of SPDR SP Pharmaceuticals is measured differently than its book value, which is the value of SPDR that is recorded on the company's balance sheet. Investors also form their own opinion of SPDR SP's value that differs from its market value or its book value, called intrinsic value, which is SPDR SP's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SPDR SP's market value can be influenced by many factors that don't directly affect SPDR SP's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.